Interferon gamma-1b for the prevention of hospital-acquired pneumonia in critically ill patients: a phase 2, placebo-controlled randomized clinical trial

被引：0
|
作者：
Antoine Roquilly
Bruno Francois
Olivier Huet
Yoann Launey
Sigismond Lasocki
Emmanuel Weiss
Melanie Petrier
Yannick Hourmant
Marwan Bouras
Karim Lakhal
Cecilia Le Bel
Delphine Flattres Duchaussoy
Laia Fernández-Barat
Adrian Ceccato
Laurent Flet
Alexandra Jobert
Jeremie Poschmann
Veronique Sebille
Fanny Feuillet
Despoina Koulenti
Antoni Torres
机构：
[1] Nantes Université,ICU Department and Inserm CIC 1435 & UMR 1092
[2] CHU Nantes,Département d’anesthésie réanimation et medecine peri
[3] INSERM,operatoire, CHRU de Brest
[4] Anesthesie Réanimation,Department of Anaesthesia, Critical Care and Perioperative Medicine
[5] CIC 1413,Department of Anesthesiology and Critical Care Medicine
[6] Nantes Université,Department of Anesthesiology and Critical Care
[7] CHU Nantes,2nd Critical Care Department
[8] INSERM,Faculty of Medicine, UQ Centre for Clinical Research
[9] Center for Research in Transplantation and Translational Immunology,undefined
[10] UMR 1064,undefined
[11] University Hospital of Limoges,undefined
[12] Université de Bretagne Occidentale,undefined
[13] Univ Rennes,undefined
[14] CHU Rennes,undefined
[15] University Hospital of Angers,undefined
[16] Université Paris Cité,undefined
[17] INSERM UMR_S1149,undefined
[18] and AP-HP Nord,undefined
[19] Hôpital Beaujon,undefined
[20] CELLEX research laboratories,undefined
[21] CibeRes (Centro de Investigación Biomédica en Red de Enfermedades Respiratorias,undefined
[22] 06/06/0028),undefined
[23] Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS),undefined
[24] Servei de Pneumologia,undefined
[25] Hospital Clinic,undefined
[26] Barcelona,undefined
[27] Universitat de Barcelona,undefined
[28] CIBERES,undefined
[29] Icrea,undefined
[30] IDIBAPS,undefined
[31] Nantes Université,undefined
[32] CHU Nantes,undefined
[33] Pharmacie,undefined
[34] Nantes Université,undefined
[35] CHU Nantes,undefined
[36] DRI,undefined
[37] Département promotion,undefined
[38] cellule vigilances recherche,undefined
[39] Nantes Université,undefined
[40] CHU Nantes,undefined
[41] DRI,undefined
[42] Plateforme de Méthodologie et de Biostatistique,undefined
[43] Nantes Université,undefined
[44] Université de Tours,undefined
[45] CHU Nantes,undefined
[46] CHU Tours,undefined
[47] INSERM,undefined
[48] SPHERE U1246,undefined
[49] Attikon University Hospital,undefined
[50] The University of Queensland,undefined
来源：
Intensive Care Medicine | 2023年 / 49卷
关键词：
Intensive care; Hospital-acquired pneumonia; Interferon-gamma; Immunotherapy; Immunosuppression;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：530 / 544
页数：14
相关论文
共 50 条
  • [31] Effects of curcuminoids on inflammatory and oxidative stress biomarkers and clinical outcomes in critically ill patients: A randomized double-blind placebo-controlled trial
    Zahedi, Hoda
    Hosseinzadeh-Attar, Mohammad Javad
    Shadnoush, Mahdi
    Sahebkar, Amirhossein
    Barkhidarian, Bahareh
    Sadeghi, Omid
    Najafi, Atabak
    Hosseini, Saeed
    Qorbani, Mostafa
    Ahmadi, Arezoo
    Ardehali, Seyed Hossein
    Norouzy, Abdolreza
    PHYTOTHERAPY RESEARCH, 2021, 35 (08) : 4605 - 4615
  • [32] Niccine®, a Nicotine Vaccine, for Relapse Prevention: A Phase II, Randomized, Placebo-Controlled, Multicenter Clinical Trial
    Tonstad, Serena
    Heggen, Eli
    Giljam, Hans
    Lagerback, Per-Ake
    Tonnesen, Philip
    Wikingsson, Lena Degling
    Lindblom, Nina
    de Villiers, Sabina
    Svensson, Torgny H.
    Fagerstrom, Karl-Olov
    NICOTINE & TOBACCO RESEARCH, 2013, 15 (09) : 1492 - 1501
  • [33] Effect of daily bathing with chlorhexidine on hospital-acquired bloodstream infection in critically ill patients: a meta-analysis of randomized controlled trials
    E Choi
    J Park
    Critical Care, 19 (Suppl 1):
  • [34] Continuous vs. bolus administration of imipenem in critically ill patients with ICU-acquired pneumonia: A randomized, controlled trial
    Sakka, S. G.
    Glauner, A.
    Kinzig-Schippers, M.
    Bulitta, J.
    Soergel, F.
    EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2004, 21 : 161 - 161
  • [35] Opaganib in Coronavirus Disease 2019 Pneumonia: Results of a Randomized, Placebo-Controlled Phase 2a Trial
    Winthrop, Kevin L.
    Skolnick, Alan W.
    Rafiq, Adnan M.
    Beegle, Scott H.
    Suszanski, Julian
    Koehne, Guenther
    Barnett-Griness, Ofra
    Bibliowicz, Aida
    Fathi, Reza
    Anderson, Patricia
    Raday, Gilead
    Eagle, Gina
    Ben-Yair, Vered Katz
    Minkowitz, Harold S.
    Levitt, Mark L.
    Gordon, Michael S.
    OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (07):
  • [36] Clinical pharmacology study of ipragliflozin in Japanese patients with type 1 diabetes mellitus: A phase 2, randomized, placebo-controlled trial
    Kaku, Kohei
    Isaka, Hiroyuki
    Toyoshima, Junko
    Sakatani, Taishi
    DIABETES OBESITY & METABOLISM, 2019, 21 (06): : 1445 - 1454
  • [37] Tolvaptan in Chinese cirrhotic patients with ascites: A randomized, placebo-controlled phase 2 trial
    Wang, Yong Feng
    Tang, Jie Ting
    Han, Tao
    Ding, Hui Guo
    Ye, Wei Jiang
    Wang, Mao Rong
    Cheng, Jun
    Yang, Yong Ping
    Chen, Cheng Wei
    Xie, Qing
    Mao, Qing
    Niu, Jun Qi
    Wang, Zheng Hua
    Wei, Zhong
    Chen, Ying Xuan
    Zeng, Min De
    Mao, Yi Min
    JOURNAL OF DIGESTIVE DISEASES, 2018, 19 (03) : 144 - 154
  • [38] Acetylsalicylic Acid Treatment in Patients With Sepsis and Septic Shock: A Phase 2, Placebo-Controlled, Randomized Clinical Trial
    Almeida, Thiago M. L.
    Freitas, Flavio G. R.
    Figueiredo, Rodrigo C.
    Houly, Sandra G.
    Azevedo, Luciano C. P.
    Cavalcanti, Alexandre B.
    Damiani, Lucas P.
    Svicero, Bianca S.
    Souza, Maria A.
    Bustamante, Cintia L. S.
    Ramos, Fernando J. S.
    Alves, Rafael S. V.
    Atallah, Fernanda C.
    Jackiu, Miriam
    Pacheco, Eduardo S.
    Schmidt, Raysa C.
    Serra, Felipe S. C.
    Tomotani, Daniere Y. V.
    Zampieri, Fernando G.
    Machado, Flavia R.
    BRICNET
    CRITICAL CARE MEDICINE, 2025, 53 (02) : e269 - e281
  • [39] Phase 1/2 Study of Lumasiran for Treatment of Primary Hyperoxaluria Type 1 A Placebo-Controlled Randomized Clinical Trial
    Frishberg, Yaacov
    Deschenes, Georges
    Groothoff, Jaap W.
    Hulton, Sally-Anne
    Magen, Daniella
    Harambat, Jerome
    van't Hoff, William G.
    Lorch, Ulrike
    Milliner, Dawn S.
    Lieske, John C.
    Haslett, Patrick
    Garg, Pushkal P.
    Vaishnaw, Akshay K.
    Talamudupula, Sandeep
    Lu, Jiandong
    Habtemariam, Bahru A.
    Erbe, David, V
    McGregor, Tracy L.
    Cochat, Pierre
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 16 (07): : 1025 - 1036
  • [40] Placebo-controlled, randomized clinical trial of azimilide for prevention of ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator
    Dorian, P
    Borggrefe, M
    Al-Khalidi, HR
    Hohnloser, SH
    Brum, JM
    Tatla, DS
    Brachmann, J
    Myerburg, RJ
    Cannom, DS
    van der Laan, M
    Holroyde, MJ
    Singer, I
    CIRCULATION, 2004, 110 (24) : 3646 - 3654
12345